In October, 2015, The Boston Globe ran an article that picked up on The Carlat Psychiatry Report's coverage of the GeneSight test. It's a promising technology, but the marketing has leap-frogged ahead of the science.
Viibryd has gone generic, but is it worth prescribing? We review all there is to know about vilazodone in this update from our #1 most read article of 2023.